Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
BrainsWay recently received de novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for treating obsessive compulsive disorder (OCD) in adults.
As the debate around rising drug prices heightens, pharmacy benefit managers are taking on more scrutiny over copays that are sometimes higher than buying the drug out of pocket.
Patients of physicians who use computerized alerts are less likely to suffer complications. The systems can also lower readmission rates, lengths of stay and costs, according to a study in the American Journal of Managed Care.
Considering the pervasiveness of opioid misuse and abuse, people find novel avenues to access the drugs. FDA Commissioner Scott Gottlieb, MD, released a statement outlining resource guide for veterinarians to prescribe opioids for animals.
A research team at University of Sydney's Save Sight Institute in Australia was recently awarded a $1.1 million grant for a biopen that treats eye wounds.
